Summary of opinion: Vabysmo, 27/06/2024 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Summary of opinion: Vabysmo, 27/06/2024 Positive
Summary of opinion: Tepkinly, 27/06/2024 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Summary of opinion: Tepkinly, 27/06/2024 Positive
Summary of opinion: Beyfortus, 27/06/2024 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Summary of opinion: Beyfortus, 27/06/2024 Positive
Summary of opinion: Betmiga, 27/06/2024 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Summary of opinion: Betmiga, 27/06/2024 Positive
Summary of opinion: Imcivree, 27/06/2024 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Summary of opinion: Imcivree, 27/06/2024 Positive
Transfer of MA templates Attachment 6.1 (Superseded)
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Transfer of MA templates Attachment 6.1 (Superseded)
Orphan designation: sotatercept Treatment of pulmonary arterial hypertension, 09/12/2020 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Orphan designation: sotatercept Treatment of pulmonary arterial hypertension, 09/12/2020 Positive
Orphan designation: Odronextamab Treatment of diffuse large B-cell lymphoma, 18/07/2022 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Orphan designation: Odronextamab Treatment of diffuse large B-cell lymphoma, 18/07/2022 Positive
Orphan designation: Odronextamab Treatment of follicular lymphoma, 18/07/2022 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Orphan designation: Odronextamab Treatment of follicular lymphoma, 18/07/2022 Positive
Summary of opinion: Pegasys, 27/06/2024 Positive
Submitted by Anonymous (not verified) on 28 June 2024 - 11:00
Summary of opinion: Pegasys, 27/06/2024 Positive